SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014802
Filing Date
2022-08-04
Accepted
2022-08-04 16:35:00
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20220630.htm   iXBRL 10-Q 1965067
2 EX-10.1 tyra-ex10_1.htm EX-10.1 158440
3 EX-31.1 tyra-ex31_1.htm EX-31.1 20688
4 EX-31.2 tyra-ex31_2.htm EX-31.2 20939
5 EX-32.1 tyra-ex32_1.htm EX-32.1 11648
6 EX-32.2 tyra-ex32_2.htm EX-32.2 11625
  Complete submission text file 0000950170-22-014802.txt   6445810

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20220630_cal.xml EX-101.CAL 33210
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20220630_def.xml EX-101.DEF 144230
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20220630.xsd EX-101.SCH 43603
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20220630_pre.xml EX-101.PRE 257850
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20220630_lab.xml EX-101.LAB 362267
51 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20220630_htm.xml XML 993946
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 221137226
SIC: 2834 Pharmaceutical Preparations